Earnings results expected in 19 days
Summary
IX1 closed Friday higher at €419, an increase of 0.22% from Thursday's close, completing a monthly increase of 5.3% or €21.1. Over the past 12 months, IX1 stock gained 5.3%.
IX1 is not paying dividends to its shareholders.
The last earnings report, released on Oct 31, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Feb 03, 2025.
IDEXX Laboratories Inc has completed 1 stock splits, with the recent split occurring on Jun 16, 2015.
The company's stock is traded on 10 different exchanges and in various currencies, with the primary listing on XFRA (EUR).
Want to track IX1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
IX1 Chart
FAQ
What Is the IDEXX Laboratories Inc(IX1) Stock Price Today?
The IX1 stock price today is €419.00.
What Stock Exchange Does IDEXX Laboratories Inc Trade On?
IDEXX Laboratories Inc is listed and trades on the NASDAQ (NGS).
What Is the Stock Symbol for IDEXX Laboratories Inc?
The stock symbol for IDEXX Laboratories Inc is "IX1".
Does IDEXX Laboratories Inc Pay Dividends? What's The Current Dividend Yield?
IX1 is not paying dividends to its shareholders.
What Is the IDEXX Laboratories Inc Market Cap?
As of today, IDEXX Laboratories Inc does not have a market cap available.
What is IDEXX Laboratories Inc Earnings Per Share?
The IDEXX Laboratories Inc EPS is 0.
What Is the Next IDEXX Laboratories Inc Earnings Date?
IDEXX Laboratories Inc will release its next earnings report on Feb 03, 2025.
Did IDEXX Laboratories Inc had any splits?
IDEXX Laboratories Inc had 1 splits and the recent split was on Jun 16, 2015.
IDEXX Laboratories Inc Profile
| - Industry | - Sector | - CEO | XFRA Exchange | US45168D1046 ISIN |
| Germany Country | - Employees | - Last Dividend | 16 Jun 2015 Last Split | - IPO Date |
Contact Information
Address: -
Phone: -
2025 © Marketlog. All Rights Reserved.
